Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia
NCT01439295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2015-11-18
Summary
Urinary ascorbyl peroxide level in the first week of life will be a good predictor of Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.
Conditions
- Bronchopulmonary Dysplasia
Sponsors & Collaborators
-
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
St. Justine's Hospital
lead OTHER
Principal Investigators
-
Ibrahim Mohamed, Mb CHB · University of Montreal, Sainte Justine Hospital
-
Jean-claude Lavoie, PhD · University of Montreal, Sainte-Justine hospital research center
Eligibility
- Min Age
- 23 Weeks
- Max Age
- 32 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- Canada
Study Locations
More Related Trials
-
MRI in BPD Subjects
NCT03657693 ·Status: RECRUITING
-
Physiologic Definition of Bronchopulmonary Dysplasia
NCT01223287 ·Status: COMPLETED
-
Antecedents of Bronchopulmonary Dysplasia
NCT00005293 ·Status: COMPLETED
-
Work of Breathing in Premature Infants at Discharge
NCT03682575 ·Status: COMPLETED
-
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
NCT05636397 ·Status: RECRUITING ·Phase: NA
-
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
NCT01607216 ·Status: COMPLETED
-
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
NCT04971694 ·Status: COMPLETED
-
Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
NCT00005289 ·Status: COMPLETED
-
Analysis of BPD in Premature Infants With Typical Imaging Changes
NCT04163822 ·Status: COMPLETED
-
Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants
NCT00573053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
NCT03542812 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
NCT01516398 ·Status: COMPLETED
-
Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns
NCT00006058 ·Status: COMPLETED
-
The Efficacy and Safety of Early Vitamin AD Supplementation in Very Preterm Infants
NCT03779776 ·Status: COMPLETED ·Phase: NA
-
Work of Breathing and Kangaroo Mother Care
NCT03683316 ·Status: COMPLETED
-
Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
NCT04890158 ·Status: TERMINATED ·Phase: NA
-
Vitamin A in Cord Blood and Preterm Outcomes
NCT07296393 ·Status: NOT_YET_RECRUITING
-
Prenatal Corticosteroids and Antioxidants in Preterm Infants
NCT00791687 ·Status: COMPLETED
-
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
NCT06373289 ·Status: RECRUITING ·Phase: NA
-
Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
NCT00742534 ·Status: WITHDRAWN ·Phase: PHASE1
-
Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants
NCT00845624 ·Status: COMPLETED
-
Early Prediction of Lung Injury in Preterm Infants Score
NCT07265583 ·Status: RECRUITING
-
Preterm Infants REtinalMicrovascular Alterations by Means of OCT Angiography
NCT05699668 ·Status: UNKNOWN ·Phase: NA
-
Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005683 ·Status: COMPLETED
-
Respiratory Outcome of Children From the FEPED Cohort
NCT03229317 ·Status: COMPLETED